KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹219 Cr | ₹177 Cr | ₹152 Cr | ₹161 Cr | ₹140 Cr |
What is the latest Total Current Liabilities ratio of KOPRAN ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹219 Cr |
Mar2023 | ₹177 Cr |
Mar2022 | ₹152 Cr |
Mar2021 | ₹161 Cr |
Mar2020 | ₹140 Cr |
How is Total Current Liabilities of KOPRAN Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹219 Cr | 23.48 | |
Mar2023 | ₹177 Cr | 16.75 | |
Mar2022 | ₹152 Cr | -5.66 | |
Mar2021 | ₹161 Cr | 14.73 | |
Mar2020 | ₹140 Cr | - |
Compare Total Current Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,477.8 Cr | 5.4% | 3.7% | 37.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹434,604.0 Cr | 0.1% | -4% | 52.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,639.0 Cr | 0.7% | -0% | 70.9% | Stock Analytics | |
CIPLA | ₹128,549.0 Cr | 0.5% | -1.7% | 29.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,956.0 Cr | 1.1% | -2.6% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,468.9 Cr | -3.6% | -8.4% | 62.9% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 5.4% |
3.7% |
37.4% |
SENSEX | -0.3% |
-2.4% |
22.4% |
You may also like the below Video Courses